Addressing Challenges in Cell Therapy & Transplant
“Addressing Challenges in Cell Therapy
— 3 October, 2022
Cantor News
Page 11
Novel Targets in Oncology: Risk vs. Reward
Thank you to all who joined Cantor’s
— 3 October, 2022
Cantor Fitzgerald’s Neurology & Psychiatry Conference
Click here to view.
— 28 September, 2022
Making the Right Edit: New Waves Being Made in the Field of Genetic Medicines
Our final panel, “Making the Right
— 22 September, 2022
Late Stage and Commercial Gene & Cell Therapy Warriors: How They Got to/Crossed the Finish Line
Our next panel, “Late Stage and
— 22 September, 2022
The ABC’s of Gene Therapies, Starting with the Importance of AAV
Our next panel, “The ABC’s of Gene Therapies,
— 21 September, 2022
Cantor Fitzgerald and Silverstein Properties Announce the Closing of a $176 Million Construction Loan for Astra Tower in Salt Lake City
— 21 September, 2022
Lunch Panel - Cantor Fitzgerald’s Cell and Genetic Medicines Conference
Our lunch session, moderated byÂ
— 20 September, 2022
You Can’t Get Anywhere Without the CAR-T Keys or GMP Van: Why Manufacturing is Essential
Our third panel, “You Can’t Get
— 20 September, 2022
CAR-T and Beyond: What Are the Next Generation Cell Therapies
Our second panel, “CAR-T and Beyond:
— 19 September, 2022
Ring Ring: Is That Large-Cap Pharma Calling? Importance of Established Partnerships in Place
Thank you to all who joined Cantor’s
— 16 September, 2022
Cantor Fitzgerald’s Oncology & HemOnc Conference
Click here to view.
— 16 September, 2022